Enoxacin ( DrugBank: Enoxacin )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
2筋萎縮性側索硬化症1

2. 筋萎縮性側索硬化症


臨床試験数 : 624 薬物数 : 611 - (DrugBank : 160) / 標的遺伝子数 : 172 - 標的パスウェイ数 : 225
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04840823
(ClinicalTrials.gov)
March 26, 202129/3/2021Enoxacin for Amyotrophic Lateral Sclerosis (ALS)A Randomized, Double-blind, Parallel Group, Single Centre, Phase 1b/2 Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Three Orally Administered Doses of Enoxacin (200mg Twice Daily, 400mg Twice Daily and 600mg Twice Daily) in Adults With Amyotrophic Lateral SclerosisAmyotrophic Lateral SclerosisDrug: Enoxacin;Drug: PlaceboMcGill UniversityWeizmann Institute of Science;Apotex Inc.Recruiting18 Years85 YearsAll36Phase 1/Phase 2Canada